Abstract
Purpose: Development of more tumor-specific radiopharmaceuticals is not enough; to understand the disease, we must study data modeling. Although fluoro-18-deoxyglucose positron emission tomography can map a multi-peak distribution of trace radioisotopes, optical tomography should also be able to redirect the distribution. Procedures: Multi-view image acquisition of small animals injected with 2-deoxy-2-[ 18F]fluoro-D-glucose began with X-ray computed tomography scanning and Cerenkov luminescence imaging. After fusion processing, utilization of the geometric row scaling and L 1/2 regularization operator effectively generates in vivo Cerenkov luminescence tomography images with the SP 3 forward model. Results: The identification is confirmed by the comparison between tumor-specific tomography from Cerenkov emission and the radioactivity measured in vitro. Conclusion: The proposed technique can quickly localize the mobility of radionuclides and uptake by organs, which provides an imaging methodology in oncology.
| Original language | English |
|---|---|
| Pages (from-to) | 286-292 |
| Number of pages | 7 |
| Journal | Molecular Imaging and Biology |
| Volume | 14 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jun 2012 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cerenkov radiation
- FDG
- Imaging radiopharmaceuticals
- Tomography
Fingerprint
Dive into the research topics of 'Fast-specific tomography imaging via cerenkov emission'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver